Flexible Electronics News

Sample Title 1

Sample Summary 1

Author Image

By: DAVID SAVASTANO

Contributing Editor, Coatings World and Ink World

Also, Catalent has recently acquired an exclusive license to market Redwood Bioscience’s SMARTag precision protein-chemical engineering technology for the development of advanced antibody drug conjugates (ADCs). Redwood’s site-specific protein modification and linker technologies enable the generation of homogenous bioconjugates engineered to enhance potency, safety and stability. Catalent will combine its GPEx cell line expression system with SMARTag for the rapid development of stable, high yielding cell lines, and a broad range of analytical and fill-finish services.

Keep Up With Our Content. Subscribe To Ink World magazine Newsletters